Gland Pharma Limited
NSE: GLANDINE068V01023·HealthcareSmallcap 250·www.glandpharma.com ↗·Mcap ₹47,985 Cr·Listed 2020
₹2,917.20▲ ₹19.80  (0.68%)
52W: ₹1,574 – ₹3,042 · Vol: 1.2L shares · Close 25 Sept
Set Alert
OverviewFinancialsChartsWavesScreenersThesisNewsPeers

News & Filings

NSE filings · newest first · 5 on record

Sun, 13 Sept, 2026

Acquisition of 100% of the equity share capital of Gland Pharma USA Inc. , a wholly-owned step down subsidiary of the Company, from Gland Pharma International Pte. Ltd, a wholly-owned subsidiary of the Company
General updateGeneral Updates16:37 IST PDF 247.04 KB XBRL
Outcome of Board Meeting held on September 13, 2026.
Board outcomeOutcome of Board Meeting16:27 IST PDF 247.04 KB XBRL
Allotment of 44,193 Equity Shares on exercise of ESOPs
General updateGeneral Updates15:39 IST PDF 250.15 KB XBRL
Options to purchase securities
FilingOptions to purchase securities15:33 IST PDF 220.95 KB XBRL
Board comments on fines levied by the Exchanges
General updateGeneral Updates15:27 IST PDF 191.65 KB XBRL
Source: NSE corporate announcements, as filed by the company. Times are IST. Press coverage is not included yet.
Filing activity · 30 days
5filings · +5 vs the 30 days before
● Board & AGM 1● Other 4
NSE filings by type. Press coverage and sentiment are not included yet.
Material vs routine · 90 days
Material events 1 in 90 days
13 SeptBoard outcome Outcome of Board Meeting held on September 13, 2026. PDF
Routine disclosures 4
other 4
Split by NSE filing category: business events (results, ratings, deals, leadership, capital actions, regulatory) versus schedules, notices and general updates. Not a view on importance.
Corporate Actions
loading…